The Future of Aging Research Is Longitudinal, Multiomic, and Single-Cell

The aging process is an intricate, lifelong biological phenomenon that heightens the likelihood of chronic diseases. As the world's population grows older, chronic illnesses become more prevalent, straining healthcare resources. Investigating the biological mechanisms behind aging is crucial for devising preventive measures and creating treatments that promote healthier aging.

Because aging is a dynamic and long-term process, research methods must incorporate multiomic insights spanning extended timeframes. Static genomic examinations at a single point in time can provide tentative indications of disease risk and prevention strategies, but they fail to capture the evolving molecular alterations linked to aging.

In contrast, longitudinal studies that gather samples over years and decades can unveil the sequence of molecular and cellular transformations preceding age-related symptoms such as frailty and cognitive decline.

Studies published in Nature Medicine and Nature Aging indicate that aging processes vary significantly between individuals and progress irregularly, emphasizing the necessity of monitoring individual biological trajectories using multiple analyses over lengthy durations. Acknowledging the significance of longitudinal research is a crucial initial step, but converting this understanding into practical applications necessitates a solid infrastructure capable of consistent sample collection, processing, and storage, while remaining resilient to the challenges that may arise throughout the course of a long-term study.

The complexity of aging is influenced by a myriad of factors, such as environmental exposures (diet, treatment history, pollution, stress), genetic predisposition, and more. Consequently, aging manifests differently in diverse, personalized ways, with certain organ systems or biological pathways aging faster in some individuals compared to others.

The molecular and cellular impacts of aging are equally diverse and extend beyond a single omics layer. While genomics remains crucial for understanding disease risk, epigenetics plays a pivotal role in aging research, as it embodies the interplay between environmental influences, molecular changes, and gene expression. Exploring other omics layers, like the proteome, can reveal clinically relevant biomarkers that capture meaningful biological modifications and facilitate the translation of research into clinical diagnostics.

Single-cell techniques expose the hidden variations within cell populations within a specific tissue, revealing that certain cell types contribute more significantly to the overall aging phenotype. Bulk omics analyses might overlook the impact of aging on particular cells and the unique contributions individual cells make to the aging process.

Age-related immune cell dysregulation increases susceptibility to infections, autoimmune disorders, and other diseases. Senescent cells, which accumulate with age, actively contribute to chronic inflammation, hinder tissue regeneration, and promote age-related diseases. Other cell types with essential roles in aging include stem cells and organ-specific cell populations that impact cardiovascular and brain health, two primary sources of age-associated morbidity.

Single-cell omics can identify distinct cell types and define their regulatory and activation states, providing deeper insights into age-related disease processes and rare cell populations.

To effectively conduct aging research, scalable infrastructure is required to preserve samples over extended periods and support consistent processing and analysis. This consistency is vital for generating reliable conclusions from samples collected at different time points and across various cohorts. Additionally, complementary multiomic platforms are essential to unravel the intricacy of aging and generate actionable insights.

Sampled is a comprehensive analytical laboratory and biorepository that combines scalable, ISBER-compliant, and CAP-accredited biobanking with a robust multiomics platform in a CLIA-certified lab covering genomics, transcriptomics, epigenomics, proteomics, single-cell, and spatial omics.